4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-17-050310
Chief Financial Officer bought 500 shares at $6.72 ($3,360)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonner Michael Chief Financial Officer | 2017-08-23 | Purchase | +500 | $6.72 | $3,360 | 15,447 | D |
| Open-market purchases · 500 sh · avg $6.72 · $3,360 | |||||||
Loading xslF345X03/doc4.xml…